Generic-Reglan Suits Doomed By Catch-22, 6th Circ. Says
A Sixth Circuit panel on Monday refused to revive seven lawsuits alleging a generic version of digestion medication Reglan caused users to develop a serious neurological condition, ruling the plaintiffs were...To view the full article, register now.
Already a subscriber? Click here to view full article